VTCN1 and breast cancer: In the present study, we surprisingly found a dynamic downregulation of B7-H4 expression when tumor cells escaped from cytotoxicity of B7-H4 CAR-T cells, which is similar to the tendency of B7-H4 expression from stage I to stage II in human breast cancer patients.